期刊
JOURNAL OF HEPATOLOGY
卷 56, 期 6, 页码 1417-1419出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jhep.2011.10.026
关键词
Liver fibrosis; Macrophage; MMP
资金
- Medical Research Council [MR/J010766/1, G0600033] Funding Source: Medline
- MRC [MR/J010766/1, G0600033] Funding Source: UKRI
- Medical Research Council [MR/J010766/1, G0600033] Funding Source: researchfish
Hepatic fibrosis is the common end point to chronic injury of varied aetiology. There is now excellent evidence in both human studies and animal models that liver fibrosis is a bidirectional process with a significant reversible component. The hepatic stellate cell (HSC), following activation to a myofibroblast phenotype, is the principal cell producing extracellular matrix (ECM) during fibrogenesis and is the main source of TIMP-1, which inhibits the endogenous matrix-degrading activity of matrix metalloproteinases (MMPs), thus promoting scar deposition. Furthermore, apoptosis of activated HSCs is a critical feature of scar resolution. However, emerging evidence indicates that it is the hepatic macrophage that is the master regulator of this dynamic fibrogenesis-fibrosis resolution paradigm.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据